# A Study of Safety and Tolerability in Subjects With Schizophrenia

> **NCT01354353** · PHASE1 · COMPLETED · sponsor: **Denovo Biopharma LLC** · enrollment: 75 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** LY2140023
- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT01354353
- **Lead sponsor:** Denovo Biopharma LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354353, "A Study of Safety and Tolerability in Subjects With Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01354353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*